Scandinavian Medical Solutions
6.84
DKK
+2.09 %
SMSMED
First North Denmark
Medical Equipment & Services
Health Care
14 following
+2.09%
+12.5%
+11.76%
+14.38%
-5.52%
-7.82%
-26.45%
+39.59%
-
+21.6%
www.scandinavian-medical.com/pages/investors
Scandinavian Medical Solutions is a Danish-based trading company specialized in purchase and resale of used diagnostic imaging equipment such as CT scanners and MR scanners of high quality. Scandinavian Medical Solutions is specialized in offering flexible solutions for customers with specific demands, which is often a better and cheaper alternative to a new and more expensive produced OEM-equipment. Scandinavian Medical Solutions was founded in 2018, and the company has been listed at Nasdaq First North in Denmark since November 2021.
Read moreRevenue
226.68M
EBIT %
6.07 %
P/E
24.43
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Denmark
SMSMED
Daily low / high price
6.7 / 6.88
DKK
Market cap
188.11M DKK
Turnover
18.43K DKK
Volume
2.7K
Latest research
Analyst
Michael Friis
Head of Equities
Kasper Lihn
Head of Research
Latest videos
Financial calendar
General meeting
09.12.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
SMS Holding ApS | 25.2 % | 25.2 % |
J. Krohn Holding ApS | 25.2 % | 25.2 % |
Fundamental Invest Afd Stock Pick | 2.9 % | 2.9 % |
Fundamental Fondsmæglerselskab A/S | 2.3 % | 2.3 % |
Jens Olsson | 2.3 % | 2.3 % |
IPO Nordic Fund A/S | 1.8 % | 1.8 % |
Fundamental Invest Afd Stock Pick II | 1.7 % | 1.7 % |
Kaptain Invest ApS | 0.2 % | 0.2 % |
M12 Invest ApS | 0.2 % | 0.2 % |
TramLux ApS | 0.2 % | 0.2 % |
Forum updates
Stay up-to-date with the latest talk about Scandinavian Medical Solutions
kan også se jeg ramte min forudsigelse ret godt Kun 0,5 mio fra begge intervaller
5/11/2023, 7:05 PM💙 1
Hvad siger de nye opjusteringer?
5/11/2023, 6:43 PM
ShowingAll content types
Dagens aktienyheder 21/11: Scandinavian Medical Solutions og Curasight
Scandinavian Medical Solutions: Lander inden for guidance i 2023/24 og forventer 6-19% omsætningsvækst og forbedret EBITDA i 2024/25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools